Merck collaborates with Isomorphic Labs to discover cancer treatments
Models & ResearchThe Neuron · 17m ago

Merck collaborates with Isomorphic Labs to discover cancer treatments

Pharmaceutical company Merck has entered a strategic research partnership with Alphabet subsidiary Isomorphic Labs. The alliance will combine proprietary laboratory data from Merck with computational models to identify new oncology drug candidates. The deal reflects ongoing pharmaceutical interest in applying machine learning to molecular discovery.

MerckIsomorphic LabsAlphabet
Read the original